Antinori A - Search Results

1

[Guidelines for the management of HCV infection in HIV-infected patients. Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani].

Antonucci G, Antinori A, Boumis E, De Longis P, Gentile M, Girardi E, Lauria FN, Narciso P, Noto P, Palmieri F, Oliva A, Petrosillo N, Rosati S, Urso R, Tocci G, Tozzi V, Visco Comandini U, Ippolito G. Antonucci G, et al. Among authors: antinori a. Infez Med. 2004 Mar;12(1):7-18. Infez Med. 2004. PMID: 15329524 Free article. Review. Italian.

2

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.

d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, Caggese L, Soscia F, Filice G, Gritti F, Narciso P, Tirelli U, Moroni M. d'Arminio Monforte A, et al. Among authors: antinori a. AIDS. 2000 Mar 31;14(5):499-507. doi: 10.1097/00002030-200003310-00005. AIDS. 2000. PMID: 10780712 Clinical Trial.

3

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, Monforte AD, Antinori A. De Luca A, et al. Among authors: antinori a. J Infect Dis. 2000 Oct;182(4):1077-83. doi: 10.1086/315817. Epub 2000 Aug 31. J Infect Dis. 2000. PMID: 10979902

4

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study.

De Luca A, Baldini F, Cingolani A, Di Giambenedetto S, Zaccarelli M, Tozzi V, Ammassari A, Murri R, Antinori A. De Luca A, et al. Among authors: antinori a. AIDS. 2000 Jul 28;14(11):1655-6. doi: 10.1097/00002030-200007280-00022. AIDS. 2000. PMID: 10983653 No abstract available.

5

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.

Girardi E, Palmieri F, Cingolani A, Ammassari A, Petrosillo N, Gillini L, Zinzi D, De Luca A, Antinori A, Ippolito G. Girardi E, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):326-31. doi: 10.1097/00126334-200104010-00006. J Acquir Immune Defic Syndr. 2001. PMID: 11317073

6

HIV infection among foreign transsexual sex workers in Rome: prevalence, behavior patterns, and seroconversion rates.

Spizzichino L, Zaccarelli M, Rezza G, Ippolito G, Antinori A, Gattari P. Spizzichino L, et al. Among authors: antinori a. Sex Transm Dis. 2001 Jul;28(7):405-11. doi: 10.1097/00007435-200107000-00008. Sex Transm Dis. 2001. PMID: 11460025

7

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.

Antinori A, Cingolani A, Alba L, Ammassari A, Serraino D, Ciancio BC, Palmieri F, De Luca A, Larocca LM, Ruco L, Ippolito G, Cauda R. Antinori A, et al. AIDS. 2001 Aug 17;15(12):1483-91. doi: 10.1097/00002030-200108170-00005. AIDS. 2001. PMID: 11504980

8

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.

Antinori A, Baldini F, Girardi E, Cingolani A, Zaccarelli M, Di Giambenedetto S, Barracchini A, De Longis P, Murri R, Tozzi V, Ammassari A, Rizzo MG, Ippolito G, De Luca A. Antinori A, et al. AIDS. 2001 Aug 17;15(12):1579-81. doi: 10.1097/00002030-200108170-00018. AIDS. 2001. PMID: 11504993

9

Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.

Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A. Antinori A, et al. J Neurovirol. 2001 Aug;7(4):323-8. doi: 10.1080/13550280152537184. J Neurovirol. 2001. PMID: 11517411

10

Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years.

Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A, Giulianelli M, Serraino D, Ippolito G. Tozzi V, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):19-27. doi: 10.1097/00042560-200109010-00004. J Acquir Immune Defic Syndr. 2001. PMID: 11579273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

901 results

Search Page